Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia

Objective:To identify factors associated with bronchodilator administration to infants with bronchopulmonary dysplasia (BPD) and evaluate inter-institutional prescribing patterns.Study Design:A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with random-effects logistic regression, we determined demographic and clinical variables associated with bronchodilator use and evaluated between-hospital variation.Result:During the study period, 33% (N=469) of 1429 infants with BPD received bronchodilators. Lengthening mechanical ventilation duration increased the odds of receiving a bronchodilator (odds ratio 19.6 (11 to 34.8) at ⩾54 days). There was profound between-hospital variation in use, ranging from 0 to 81%.Conclusion:Bronchodilators are frequently administered to infants with BPD at US children’s hospitals with increasing use during the first hospital month. Increasing positive pressure exposure best predicts bronchodilator use. Frequency and treatment duration vary markedly by institution even after adjustment for confounding variables.

• Publication year

  2014

• Venue

  Journal of Perinatology

• Publication date

  2014-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jp.2014.141PMID 25102319PMCID 4281278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticholinergic, antimuscarinic bronchodilators.

  2015cited by this paper
• Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia

  2013cited by this paper
• Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.

  2012cited by this paper
• Drug therapies in bronchopulmonary dysplasia: debunking the myths.

  2009cited by this paper
• Chronic lung disease after premature birth.

  2007cited by this paper
• Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set

  2006cited by this paper
• Summary Proceedings From the Bronchopulmonary Dysplasia Group

  2006cited by this paper
• Efficacy and Tolerance of High-Dose Inhaled Ipratropium Bromide vs. Terbutaline in Intubated Premature Human Neonates

  2006cited by this paper
• Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia

  2005cited by this paper
• Statement on the care of the child with chronic lung disease of infancy and childhood.

  2003cited by this paper
• Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.

  2001cited by this paper
• Bronchopulmonary dysplasia.

  2001cited by this paper
• Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study

  1998cited by this paper
• Bases physiologiques de l'utilisation des antagonistes muscariniques dans les dysplasies bronchopulmonaires

  1995cited by this paper
• [Physiological basis for the use of muscarine antagonists in bronchopulmonary dysplasia].

  1995cited by this paper
• THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

  1994cited by this paper
• Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia.

  1990cited by this paper
• Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia

  1989cited by this paper
• Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia.

  1989cited by this paper
• Effects of metaproterenol on pulmonary mechanics, oxygenation, and ventilation in infants with chronic lung disease.

  1987cited by this paper
• Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.

  1987cited by this paper
• Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.

  1987cited by this paper
• Bronchopulmonary dysplasia.

  1986cited by this paper
• Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia.

  1981cited by this paper

• Respiratory Practices to Prevent or Treat Evolving Bronchopulmonary Dysplasia: A European Survey.

  2026cites this paper
• Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants

  2025cites this paper
• Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.

  2024cites this paper
• A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit

  2024cites this paper
• Comprehensive pulmonary function analysis identifies predominant obstructive phenotype in former premature infants around one year of age

  2024cites this paper
• The prevention and management strategies for neonatal chronic lung disease

  2023cites this paper
• Displasia Broncopulmonar: Revisão Narrativa Da Literatura

  2023cites this paper
• Outpatient management of established bronchopulmonary dysplasia: An update.

  2023cites this paper
• Validity and reliability of the behavioral signs of respiratory instability (BSRI) © scale during activity for infants with bronchopulmonary dysplasia

  2023cites this paper
• Respiratory management in the premature neonate

  2023cites this paper
• Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia

  2022cites this paper
• Pharyngeal biorhythms during oral milk challenge in high‐risk infants: Do they predict chronic tube feeding?

  2022cites this paper
• Neonatal Laryngotracheal Anomalies.

  2022cites this paper
• Oscillatory mechanics response to inhaled bronchodilators in very preterm infants: a retrospective study.

  2022cites this paper
• Prospective Risk Stratification Identifies Healthcare Utilization Associated with Home Oxygen Therapy for Infants with Bronchopulmonary Dysplasia.

  2022cites this paper
• Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

  2022cites this paper
• An Update on the Prevention and Management of Bronchopulmonary Dysplasia

  2021cites this paper
• BPD treatments: The never-ending smorgasbord.

  2021cites this paper
• Established severe BPD: is there a way out? Change of ventilatory paradigms

  2021cites this paper
• Response to first dose of inhaled albuterol in mechanically ventilated preterm infants

  2021cites this paper
• Optimizing respiratory management in preterm infants: a review of adjuvant pharmacotherapies

  2021cites this paper
• Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia

  2021cites this paper
• Imaging in neonatal respiratory disease.

  2021cites this paper
• Inhaled Pharmacotherapy for Neonates: A Narrative Review

  2021cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020cites this paper
• Tolerability and efficacy of two doses of aerosolized albuterol in ventilated infants with BPD: A randomized controlled crossover trial

  2020cites this paper
• Bronchopulmonary Dysplasia: Then, Now, and Next

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Low Dose Hyperoxia Primes Airways for Fibrosis in Mice after Influenza A Infection

  2020cites this paper
• Bronchopulmonary Dysplasia: An Overview

  2020influential citation
• Perinatal Palliative Care: A Clinical Guide

  2020cites this paper
• Non-pain Symptom Management

  2020cites this paper
• Burden of Chronic Lung Disease on the Caregivers

  2020cites this paper
• Pharmacologic Management of Severe Bronchopulmonary Dysplasia.

  2020cites this paper
• Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants

  2020cites this paper
• Phenotypes of Bronchopulmonary Dysplasia

  2020cites this paper
• Advances in treating bronchopulmonary dysplasia

  2019cites this paper
• Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals

  2019cites this paper
• Pediatric Pulmonology

  2019cites this paper
• Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.

  2019cites this paper
• Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium

  2019cites this paper
• Aerosol therapy in relation to retinopathy of prematurity in mechanically ventilated preterm infants

  2019cites this paper
• Pediatric Respirology and Critical Care Medicine

  2018cites this paper
• Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

  2018cites this paper
• An update on the post-NICU discharge management of bronchopulmonary dysplasia.

  2018cites this paper
• [Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants].

  2018cites this paper
• Bronchopulmonary dysplasia: Myths of pharmacologic management.

  2017cites this paper
• The roles of drug therapy given via the endotracheal tube to neonates

  2017cites this paper
• Mean Platelet Volume as a Marker of Intraventricular Hemorrhage in Very Premature Infants

  2017cites this paper
• Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries.

  2017cites this paper
• Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia

  2017cites this paper
• Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions

  2016cites this paper
• S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia

  2016cites this paper
• Impact of Process Optimization and Quality Improvement Measures on Neonatal Feeding Outcomes at an All-Referral Neonatal Intensive Care Unit.

  2016cites this paper